rethinkPeptides Search
Menu
Research citation

Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.

International journal of pharmaceutics, 551(1-2), 14-22

Citation

Xiang, Yucheng; Shan, Wei; Huang, Yuan. (2018). Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.. International journal of pharmaceutics, 551(1-2), 14-22. https://doi.org/10.1016/j.ijpharm.2018.09.011